ResMed Pre-Tax Profit Margin 2010-2023 | RMD
Current and historical pre-tax profit margin for ResMed (RMD) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. ResMed pre-tax profit margin for the three months ending December 31, 2023 was .
| ResMed Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $4.50B | $1.10B | 24.36% |
| 2023-09-30 | $4.38B | $1.11B | 25.42% |
| 2023-06-30 | $4.22B | $1.10B | 26.10% |
| 2023-03-31 | $4.02B | $1.06B | 26.47% |
| 2022-12-31 | $3.76B | $1.00B | 26.57% |
| 2022-09-30 | $3.63B | $0.96B | 26.57% |
| 2022-06-30 | $3.58B | $0.96B | 26.82% |
| 2022-03-31 | $3.54B | $0.96B | 27.15% |
| 2021-12-31 | $3.44B | $0.95B | 27.67% |
| 2021-09-30 | $3.35B | $0.93B | 27.68% |
| 2021-06-30 | $3.20B | $0.88B | 27.65% |
| 2021-03-31 | $3.09B | $0.86B | 27.73% |
| 2020-12-31 | $3.09B | $0.83B | 26.88% |
| 2020-09-30 | $3.03B | $0.80B | 26.40% |
| 2020-06-30 | $2.96B | $0.73B | 24.83% |
| 2020-03-31 | $2.89B | $0.62B | 21.38% |
| 2019-12-31 | $2.78B | $0.56B | 20.26% |
| 2019-09-30 | $2.70B | $0.53B | 19.67% |
| 2019-06-30 | $2.61B | $0.52B | 19.92% |
| 2019-03-31 | $2.53B | $0.56B | 22.34% |
| 2018-12-31 | $2.46B | $0.56B | 22.65% |
| 2018-09-30 | $2.41B | $0.55B | 22.95% |
| 2018-06-30 | $2.34B | $0.52B | 22.26% |
| 2018-03-31 | $2.27B | $0.50B | 22.08% |
| 2017-12-31 | $2.20B | $0.48B | 21.86% |
| 2017-09-30 | $2.13B | $0.43B | 20.42% |
| 2017-06-30 | $2.07B | $0.42B | 20.28% |
| 2017-03-31 | $2.03B | $0.41B | 20.41% |
| 2016-12-31 | $1.97B | $0.42B | 21.09% |
| 2016-09-30 | $1.89B | $0.43B | 22.87% |
| 2016-06-30 | $1.84B | $0.44B | 23.86% |
| 2016-03-31 | $1.77B | $0.43B | 24.01% |
| 2015-12-31 | $1.74B | $0.43B | 24.74% |
| 2015-09-30 | $1.71B | $0.43B | 25.32% |
| 2015-06-30 | $1.68B | $0.44B | 25.98% |
| 2015-03-31 | $1.64B | $0.44B | 26.77% |
| 2014-12-31 | $1.62B | $0.44B | 27.10% |
| 2014-09-30 | $1.58B | $0.43B | 27.33% |
| 2014-06-30 | $1.56B | $0.43B | 27.72% |
| 2014-03-31 | $1.56B | $0.41B | 26.50% |
| 2013-12-31 | $1.54B | $0.41B | 26.41% |
| 2013-09-30 | $1.53B | $0.40B | 25.81% |
| 2013-06-30 | $1.52B | $0.39B | 25.40% |
| 2013-03-31 | $1.47B | $0.40B | 26.88% |
| 2012-12-31 | $1.44B | $0.37B | 25.87% |
| 2012-09-30 | $1.39B | $0.36B | 25.61% |
| 2012-06-30 | $1.37B | $0.33B | 24.25% |
| 2012-03-31 | $1.34B | $0.31B | 23.15% |
| 2011-12-31 | $1.30B | $0.30B | 22.79% |
| 2011-09-30 | $1.28B | $0.29B | 22.96% |
| 2011-06-30 | $1.24B | $0.30B | 24.46% |
| 2011-03-31 | $1.19B | $0.30B | 25.06% |
| 2010-12-31 | $1.16B | $0.30B | 25.54% |
| 2010-09-30 | $1.13B | $0.28B | 24.82% |
| 2010-06-30 | $1.09B | $0.26B | 23.88% |
| 2010-03-31 | $1.05B | $0.25B | 23.84% |
| 2009-12-31 | $1.00B | $0.24B | 23.65% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.315B | $4.223B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.435B | 23.89 |
| Stryker (SYK) | United States | $127.230B | 30.47 |
| Medtronic (MDT) | Ireland | $113.715B | 16.10 |
| Boston Scientific (BSX) | United States | $109.372B | 34.84 |
| EssilorLuxottica (ESLOY) | France | $101.565B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.132B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.219B | 27.90 |
| Terumo (TRUMY) | Japan | $26.460B | 37.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.501B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.940B | 15.93 |
| Baxter (BAX) | United States | $17.922B | 12.74 |
| Insulet (PODD) | United States | $12.984B | 57.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.436B | 27.59 |
| BellRing Brands (BRBR) | United States | $7.595B | 35.72 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.01 |
| Haemonetics (HAE) | United States | $4.815B | 23.82 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.103B | 12.44 |
| Envista Holdings (NVST) | United States | $3.288B | 13.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.244B | 15.44 |
| QuidelOrtho (QDEL) | United States | $2.946B | 16.35 |
| Neogen (NEOG) | United States | $2.905B | 27.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.791B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.760B | 54.67 |
| TG Therapeutics (TGTX) | United States | $2.692B | 75.74 |
| ICU Medical (ICUI) | United States | $2.589B | 22.85 |
| Agios Pharmaceuticals (AGIO) | United States | $1.987B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.828B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.744B | 51.10 |
| Warby Parker (WRBY) | United States | $1.600B | 0.00 |
| InMode (INMD) | Israel | $1.565B | 8.32 |
| Owens & Minor (OMI) | United States | $1.462B | 12.74 |
| AdaptHealth (AHCO) | United States | $1.312B | 9.75 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| AtriCure (ATRC) | United States | $1.077B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.926B | 0.00 |
| Evolus (EOLS) | United States | $0.858B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.767B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.728B | 15.50 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.623B | 14.65 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| PetIQ (PETQ) | United States | $0.583B | 19.05 |
| TerrAscend (TSNDF) | Canada | $0.525B | 0.00 |
| Jin Medical (ZJYL) | China | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.486B | 30.43 |
| ZimVie (ZIMV) | United States | $0.463B | 39.49 |
| Aurora Cannabis (ACB) | Canada | $0.415B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.387B | 12.45 |
| Cerus (CERS) | United States | $0.362B | 0.00 |
| Biote (BTMD) | United States | $0.362B | 8.34 |
| Zynex (ZYXI) | United States | $0.350B | 47.83 |
| MacroGenics (MGNX) | United States | $0.321B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.19 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.66 |
| Ayr Wellness (AYRWF) | United States | $0.222B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Omeros (OMER) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.179B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
| Quipt Home Medical (QIPT) | United States | $0.145B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.19 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 18.29 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 8.54 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.62 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |